XML 227 R20.htm IDEA: XBRL DOCUMENT v3.26.3
Supplemental Financial Information
 9 Months Ended
Sep. 30, 2026
Other Liabilities Disclosure [Abstract]  
Supplemental Financial Information Supplemental Financial Information
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheets to the total of the same amounts shown on the condensed consolidated statements of cash flows:
September 30, 2026December 31, 2025
Cash and cash equivalents$96,139 $104,997 
Restricted cash (included in other assets)993 992 
Total$97,132 $105,989 
Restricted cash as of September 30, 2026 and December 31, 2025 primarily consists of money market deposit accounts that secure an irrevocable standby letter of credit that serves as collateral for a security deposit for operating leases.
Prepaid expenses and other current assets consisted of the following:
September 30, 2026December 31, 2025
Prepaid expenses$11,303 $7,174 
Other current assets1,640 1,511 
Total$12,943 $8,685 
Accounts payable and accrued expenses consisted of the following:
September 30, 2026December 31, 2025
Accounts payable$3,319 $2,461 
Accrued expenses23,606 44,659 
Third party payor reserves, short-term714 4,965 
Legal reserves4,787 5,560 
Total
$32,426 $57,645 
Other current liabilities consisted of the following:
September 30, 2026December 31, 2025
Accrued compensation$19,631 $29,638 
Accrued severance1,635 771 
Due to related parties339 643 
Current portion of long-term debt— 4,542 
Short-term contingent consideration liability5,353 5,444 
Short-term warrant liability— 1,100 
Other6,196 4,721 
Total
$33,154 $46,859 
Other liabilities consisted of the following:
September 30, 2026December 31, 2025
Long-term contingent consideration liability— 1,570 
Other71 71 
Total$71 $1,641 
2024 Sales Agreement
The Company entered into a sales agreement (the “2024 Sales Agreement”) with TD Securities (USA) LLC (“TD Cowen”) in April 2024, pursuant to which the Company may, but is not obligated to, offer and sell, from time to time, shares of its Class A common stock with an aggregate offering price up to $75.0 million through TD Cowen, as sales agent, subject to the terms and conditions described in the 2024 Sales Agreement and SEC rules and regulations (the “prior ATM offering”). During the nine months ended September 30, 2025, the Company issued 251,367 shares of its Class A common stock in connection with the prior ATM offering at an average price of $106.56 per share. Proceeds received, net of agent fees and other offering expenses, were $25.6 million. During the year ended December 31, 2025, the Company sold the maximum amount of shares in the prior ATM offering which resulted in the automatic termination of the 2024 Sales Agreement.
2025 Sales Agreement
The Company entered into an additional sales agreement (the “2025 Sales Agreement”) with TD Securities (USA) LLC (“TD Cowen”) in October 2025, pursuant to which the Company may, but is not obligated to, offer and sell, from time to time, shares of its Class A common stock with an aggregate offering price up to $100.0 million through TD Cowen, as sales agent, subject to the terms and conditions described in the 2025 Sales Agreement and SEC rules and regulations (the “ATM offering”). During the year ended December 31, 2025, the Company issued 147,583 shares of its Class A common stock in connection with this ATM offering at an average price of $147.44 per share and the proceeds received, net of agent fees and other offering expenses, were $21.1 million. The Company did not issue any shares of its Class A common stock in connection with this ATM offering during the nine months ended September 30, 2026. As of September 30, 2026, approximately $78.2 million of capacity remained available under this ATM offering.